SCIENTIFIC AND REGULATORY PERSPECTIVES ON DRUG INTERACTION EVALUATION DURING DRUG DEVELOPMENT

被引：0
|
作者：
Zhang, Lei [1 ]
机构：
[1] US FDA, Off Clin Pharmacol, Off Translat Sci, CDER, Silver Spring, MD USA
来源：
DRUG METABOLISM REVIEWS | 2014年 / 45卷
关键词：
D O I：
暂无
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：18 / 18
页数：1
相关论文
共 50 条
  • [1] A scientific perspective on drug interaction evaluation during drug development
    Zhang, Lei
    [J]. DRUG METABOLISM REVIEWS, 2016, 48 : 16 - 16
  • [2] DRUG INTERACTION STUDIES DURING DRUG DEVELOPMENT: CURRENT STATUS AND REGULATORY PERSPECTIVES IN JAPAN
    Sato, Masanobu
    Ishiguro, Akihiro
    Iwata, Daisuke
    Kishi, Tatsuo
    Hirano, Mai
    Hoshino, Motohiro
    Nagai, Naomi
    [J]. DRUG METABOLISM REVIEWS, 2014, 45 : 116 - 116
  • [3] Regulatory and Scientific Aspects of Drug-Drug Interaction Studies
    Greenblatt, David J.
    [J]. CLINICAL PHARMACOLOGY IN DRUG DEVELOPMENT, 2012, 1 (02): : 43 - +
  • [4] Transporters in Drug Development: Scientific and Regulatory Considerations
    Zhang, Lei
    Huang, Shiew-Mei
    Reynolds, Kellie
    Madabushi, Rajanikanth
    Zineh, Issam
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2018, 104 (05) : 793 - 796
  • [5] Scientific and regulatory evaluation of mechanistic in silico drug and disease models in drug development: Building model credibility
    Musuamba, Flora T.
    Rusten, Ine Skottheim
    Lesage, Raphaelle
    Russo, Giulia
    Bursi, Roberta
    Emili, Luca
    Wangorsch, Gaby
    Manolis, Efthymios
    Karlsson, Kristin E.
    Kulesza, Alexander
    Courcelles, Eulalie
    Boissel, Jean-Pierre
    Rousseau, Cecile F.
    Voisin, Emmanuelle M.
    Alessandrello, Rossana
    Curado, Nuno
    Dall'ara, Enrico
    Rodriguez, Blanca
    Pappalardo, Francesco
    Geris, Liesbet
    [J]. CPT-PHARMACOMETRICS & SYSTEMS PHARMACOLOGY, 2021, 10 (08): : 804 - 825
  • [6] Utility of Biomarker-Informed Drug Interaction Evaluation in Drug Development and Regulatory Decision Making
    Ishiguro, Akihiro
    Kusuhara, Hiroyuki
    Kimoto, Emi
    Miyoshi, So
    Mizuno, Katsuhiko
    Hoshino, Motohiro
    Suzuki, Hiroshi
    [J]. CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024,
  • [7] A REGULATORY PERSPECTIVE "TRANSPORTERS IN DRUG DEVELOPMENT: SCIENTIFIC AND REGULATORY CONSIDERATIONS"
    Zhang, Lei K.
    [J]. DRUG METABOLISM AND PHARMACOKINETICS, 2020, 35 (01) : S2 - S2
  • [8] Ethical, regulatory and scientific challenges in paediatric drug development
    Rose K.
    [J]. Pharmaceutical Medicine, 2008, 22 (4) : 221 - 234
  • [9] Drug-induced QT interval prolongation: regulatory perspectives and drug development
    Shah, RR
    [J]. ANNALS OF MEDICINE, 2004, 36 : 47 - 52
  • [10] Editorial: Drug development of herbal medicines: Regulatory perspectives
    Bilia, Anna Rita
    Mukherjee, Pulok Kumar
    Andrade-Cetto, Adolfo
    Katiyar, Chandra Kant
    Bachar, Sitesh C. C.
    Matsabisa, Motlalepula Gilbert
    Mandal, Subhash C. C.
    [J]. FRONTIERS IN PHARMACOLOGY, 2022, 13
12345